share_log

Stifel Upgrades Cipher Pharmaceuticals to Speculative Buy, Raises Price Target to $4.75

Stifel Upgrades Cipher Pharmaceuticals to Speculative Buy, Raises Price Target to $4.75

Stifel将Cipher Pharmicals上调至投机买入,将目标股价上调至4.75美元
Benzinga ·  2023/06/01 12:56

Stifel analyst Justin Keywood upgrades Cipher Pharmaceuticals (OTC:CPHRF) from Hold to Speculative Buy and raises the price target from C$0.95 to C$4.75.

Stifel的分析师贾斯汀·基伍德将Cipher Pharmaceuticals(OTC:CPHRF)的持有评级升级为投机买入,并将目标价格从加拿大0.95元上调至加拿大4.75元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发